TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 314 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $276,567 | -1.8% | 21,373 | +5.4% | 0.12% | -46.3% |
Q1 2024 | $281,661 | -5.1% | 20,278 | -2.5% | 0.21% | -4.5% |
Q4 2023 | $296,816 | -19.8% | 20,800 | -13.1% | 0.22% | -13.8% |
Q3 2023 | $370,274 | +85.1% | 23,935 | +101.8% | 0.26% | +246.7% |
Q2 2021 | $200,000 | -18.4% | 11,863 | -11.8% | 0.08% | -10.7% |
Q4 2020 | $245,000 | – | 13,444 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Y.D. More Investments Ltd | 1,498,811 | $24,700,380 | 5.57% |
TFG Asset Management GP Ltd | 1,903,662 | $31,372,350 | 4.20% |
Clean Yield Group | 542,342 | $8,937,796 | 3.81% |
MANAGED ASSET PORTFOLIOS, LLC | 1,467,952 | $24,192 | 3.67% |
Mondrian Investment Partners LTD | 4,081,715 | $67,266,663 | 1.48% |
Sippican Capital Advisors | 82,235 | $1,355,233 | 1.30% |
Psagot Value Holdings Ltd. / (Israel) | 174,300 | $2,830 | 1.18% |
Clal Insurance Enterprises Holdings Ltd | 4,365,500 | $71,943 | 1.08% |
Legacy Wealth Asset Management, LLC | 123,303 | $2,032,033 | 0.73% |
BRANDES INVESTMENT PARTNERS, LP | 1,817,972 | $29,960,175 | 0.64% |